C00-C96.9 | All malignant neoplasms (excl. C44) |  |  |
C00-C14 | Head and neck (excl. Larynx) |  |  |
C00-C14,C30-C32 | Head and neck (incl. Larynx) |  |  |
C00 | Lip |  |  |
C01-C06 | Oral region |  |  |
C01 | Base of tongue |  |  |
C02 | Tongue without base of tongue |  |  |
C03 | Gum |  |  |
C04 | Floor of mouth |  |  |
C05 | Palate |  |  |
C06 | Mouth |  |  |
C07,C08 | Parotid glands and unspecified major salivary |  |  |
C09-C10 | Tonsil and oropharynx |  |  |
C09-C14 | Pharynx |  |  |
C09 | Tonsil |  |  |
C11 | Nasopharynx |  |  |
C12,C13 | Piriform sinus and hypopharynx |  |  |
C14 | Other oral and pharynx |  |  |
C15-C26 | Digestive organs |  |  |
C15 | Oesophagus |  |  |
C16 | Stomach |  |  |
C17 | Small intestine |  |  |
C18-C21 | Colon, rectosigmoid, rectum, anus and anal canal |  |  |
C18-C20 | Colon, rectosigmoid and rectum |  |  |
C18 | Colon |  |  |
C18.1 | Appendix |  |  |
C19,C20 | Rectosigmoid junction and rectum |  |  |
C21 | Anus and anal canal |  |  |
C22 | Liver and intrahepatic bile ducts |  |  |
C22.0 | Liver cell carcinoma |  |  |
C22.1 | Cholangiocarcinoma |  |  |
C23 | Gallbladder |  |  |
C24 | Biliary-tract |  |  |
C25 | Pancreas |  |  |
C26 | Other digestive organs |  |  |
C30,C31 | Nasal cavity and middle ear and accessory sinuses |  |  |
C32 | Larynx |  |  |
C33,C34 | Trachea and lung |  |  |
C34 | Lung |  |  |
C34 SCLC | Small cell lung cancer |  |  |
C34 NSCLC | Non-small cell lung cancer |  |  |
C37 | Tymus |  |  |
C38 | Heart, mediastinum and pleura |  |  |
C40,C41 | Bone and articular cartilage |  |  |
C43 | Malignant Melanoma |  |  |
D03 | Melanoma in situ |  |  |
C44 | Skin other |  |  |
C44 cSCC | Squamous-cell skin carcinoma |  |  |
C44 MCC | Merkel cell carcinoma |  |  |
D04 | Carcinoma in situ of skin |  |  |
C45-C49 | Mesothelial and soft tissue |  |  |
C00-C97 Sarcoma | Sarcoma morphological |  |  |
C45 | Mesothelioma |  |  |
C45.0 | Mesothelioma of pleura |  |  |
C46 | Kaposi sarcoma |  |  |
C47 | Peripheral nerves |  |  |
C48 | Peritoneum |  |  |
C49 | Other connective and soft tissue |  |  |
C50 | Breast (female) |  |  |
C50 | Breast (male) |  |  |
D05 | Carcinoma in situ of breast (female) |  |  |
MPD | Mammarian Paget's disease (female) |  |  |
C51-C58 | Female genital organs |  |  |
C51 | Vulva |  |  |
C52 | Vagina |  |  |
C53-C55 | Uterus |  |  |
C53 | Cervix uteri |  |  |
D06 | Carcinoma in situ of cervix |  |  |
C54 | Corpus uteri |  |  |
C56 | Ovary (invasive) |  |  |
D39.1 | Ovary borderline |  |  |
C57 | Female genitale |  |  |
C60-C68 | Male genital organs and urinary tract |  |  |
C60 | Penis |  |  |
C61 | Prostate |  |  |
C62 | Testis |  |  |
C64-C68 | Urinary tract |  |  |
C64-C66, C68 | Upper urinary tract, unspecified urinary organs |  |  |
C64 | Kidney (excl. renal pelvis) |  |  |
C65 | Renal pelvis |  |  |
C66 | Ureter |  |  |
C67 | Bladder (invasive) |  |  |
D09.0,D41.4 | Bladder non-invasive |  |  |
C69 | Eye |  |  |
C69 MEL | Eye melanoma |  |  |
C70-C72 | Brain and other parts of central nervous system |  |  |
C70 | Meninges |  |  |
D32 | Benign neoplasm of meninges |  |  |
C71 | Brain |  |  |
C71 AST | Astrocytoma |  |  |
C71 GB | Glioblastoma |  |  |
C72 | Spinal cord |  |  |
D33 | Benign neoplasm of brain and other parts of CNS |  |  |
C73 | Thyroid gland |  |  |
C73 ANA | Thyroid gland, anaplastic |  |  |
C73 FOLL | Thyroid gland, follicular |  |  |
C73 MED | Thyroid gland, medullary |  |  |
C73 PAP | Thyroid gland, papillary |  |  |
C74 | Adrenal gland |  |  |
C75 | Other endocrine glands |  |  |
C7680 | Secondary and unspecified sites |  |  |
C7780 | Secondary and unknown sites |  |  |
C80 | Unknown primary (CUP) |  |  |
C81-C96 | Systemic neoplasms |  |  |
C81 | Hodgkin lymphoma |  |  |
C82-C86 | Non-Hodgkin lymphoma |  |  |
C82 | Follicular lymphoma |  |  |
C83 | Non-follicular lymphoma |  |  |
C83.1 | Mantle cell lymphoma |  |  |
C83.3 | Diffuse large B-cell lymphoma |  |  |
C83.7 | Burkitt lymphoma |  |  |
C84 | Mature T/NK-cell lymphomas |  |  |
C85 | Other and unspecified types of NHL |  |  |
C86 | Other specified types of T/NK-cell lymphoma |  |  |
C88,C90 | Immunoproliferative and plasmacellular disease |  |  |
C88.4 | MALT lymphoma |  |  |
C90 | Multiple myeloma and malign plasma cell neoplasms |  |  |
C90.0 | Multiple myeloma |  |  |
C91-C95 | Leukaemias |  |  |
C91 | Lymphoid leukaemia |  |  |
C91.0 | Acute lymphoblastic leukaemia (ALL) |  |  |
C91.1 | Chronic lymphocytic leukaemia (CLL) |  |  |
C91,C92,C94.4 | Acute leukaemias |  |  |
C92 | Myeloid leukaemia |  |  |
C92.0 | Acute myeloblastic leukaemia (AML) |  |  |
C92.1,C92.2 | Chronic myeloid leukaemia (CML) |  |  |
C93-C95 | Other leukaemias |  |  |
D45 | Polycythaemia vera |  |  |
D46 | Myelodysplastic syndromes |  |  |
C96 | Systemic disease |  |  |
GIST | Gastrointestinal stromal tumor |  |  |
GEP-NET | Gastroenteropancreatic neuroendocrine tumor |  |  |
GI-NET | Gastrointestinal neuroendocrine tumor |  |  |
B-NET | Pulmonary neuroendocrine tumor |  |  |
P-NET | Pancreatic neuroendocrine tumor |  |  |
D00-D09 | In-situ neoplasms |  |  |
D37-D48 | Neoplasms of uncertain or unknown behaviour |  |  |